Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
America's Car Mart
CRMT
$26.1M
| $1.22M | ﹤0.01% |
23,772
-19,900
| -46% | -$907K |
|
2377
CNB Financial Corp
CCNE
$1.03B
| $1.22M | ﹤0.01% |
49,001
-5,700
| -10% | -$149K |
|
2378
Epsilon Energy
EPSN
$169M
| $1.22M | ﹤0.01% |
196,100
-16,700
| -8% | -$98.4K |
|
2379
SoundThinking
SSTI
$80.8M
| $1.22M | ﹤0.01% |
93,132
+13,900
| +18% | +$167K |
|
2380
Century Therapeutics
IPSC
$349M
| $1.21M | ﹤0.01% |
1,202,885
+714,685
| +146% | +$973K |
|
|
NFGC
2381
New Found Gold
NFGC
$657M
| $1.21M | ﹤0.01% |
667,053
+150,253
| +29% | +$307K |
|
2382
Boston Omaha
BOC
$418M
| $1.21M | ﹤0.01% |
85,600
-109,100
| -56% | -$1.62M |
|
2383
First US Bancshares
FUSB
$90.8M
| $1.21M | ﹤0.01% |
96,221
-600
| -0.6% | -$7.46K |
|
2384
Inseego
INSG
$77.5M
| $1.21M | ﹤0.01% |
117,941
+78,495
| +199% | +$1.15M |
|
2385
Avista
AVA
$3.27B
| $1.21M | ﹤0.01% |
+33,000
| New | +$1.24M |
|
|
OPLN
2386
Openlane
OPLN
$4.38B
| $1.21M | ﹤0.01% |
60,800
-90,900
| -60% | -$1.68M |
|
2387
AMCON Distributing
DIT
$66.4M
| $1.21M | ﹤0.01% |
14,108
-120
| -0.8% | -$10.7K |
|
2388
Cumberland Pharmaceuticals
CPIX
$118M
| $1.2M | ﹤0.01% |
507,163
-21,000
| -4% | -$30.9K |
|
2389
Vanguard S&P 500 Value ETF
VOOV
$6.81B
| $1.2M | ﹤0.01% |
6,500
-4,800
| -42% | -$921K |
|
2390
Precigen
PGEN
$2.2B
| $1.2M | ﹤0.01% |
1,067,645
-532,545
| -33% | -$454K |
|
2391
iShares MSCI Japan ETF
EWJ
$23.1B
| $1.19M | ﹤0.01% |
17,763
-1,100
| -6% | -$75.9K |
|
2392
Twin Disc
TWIN
$352M
| $1.19M | ﹤0.01% |
101,393
-1,000
| -1% | -$11.9K |
|
2393
Champions Oncology
CSBR
$70.7M
| $1.19M | ﹤0.01% |
138,839
+18,848
| +16% | +$94.8K |
|
2394
Envela
ELA
$417M
| $1.19M | ﹤0.01% |
165,604
-17,500
| -10% | -$109K |
|
|
EFXT
2395
Enerflex
EFXT
$2.73B
| $1.19M | ﹤0.01% |
119,300
+13,291
| +13% | +$107K |
|
2396
1stdibs.com
DIBS
$162M
| $1.19M | ﹤0.01% |
335,200
-80,300
| -19% | -$325K |
|
2397
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $1.18M | ﹤0.01% |
29,300
-13,700
| -32% | -$566K |
|
2398
Allogene Therapeutics
ALLO
$718M
| $1.18M | ﹤0.01% |
554,541
-87,468
| -14% | -$216K |
|
2399
BOK Financial
BOKF
$8.88B
| $1.18M | ﹤0.01% |
11,077
+5,500
| +99% | +$614K |
|
2400
Karooooo
KARO
$1.93B
| $1.18M | ﹤0.01% |
26,093
-4,508
| -15% | -$190K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.